CN103038642B - 方法、阵列及其用途 - Google Patents

方法、阵列及其用途 Download PDF

Info

Publication number
CN103038642B
CN103038642B CN201180035844.4A CN201180035844A CN103038642B CN 103038642 B CN103038642 B CN 103038642B CN 201180035844 A CN201180035844 A CN 201180035844A CN 103038642 B CN103038642 B CN 103038642B
Authority
CN
China
Prior art keywords
sample
purposes
antibody
biomarker
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180035844.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN103038642A (zh
Inventor
C·A·K·博雷贝克
C·L·B·温格伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Publication of CN103038642A publication Critical patent/CN103038642A/zh
Application granted granted Critical
Publication of CN103038642B publication Critical patent/CN103038642B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201180035844.4A 2010-06-11 2011-06-09 方法、阵列及其用途 Expired - Fee Related CN103038642B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1009798.8 2010-06-11
GBGB1009798.8A GB201009798D0 (en) 2010-06-11 2010-06-11 Method,array and use thereof
PCT/GB2011/000865 WO2011154698A2 (en) 2010-06-11 2011-06-09 Method,array and use thereof

Publications (2)

Publication Number Publication Date
CN103038642A CN103038642A (zh) 2013-04-10
CN103038642B true CN103038642B (zh) 2017-02-22

Family

ID=42471508

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180035844.4A Expired - Fee Related CN103038642B (zh) 2010-06-11 2011-06-09 方法、阵列及其用途

Country Status (11)

Country Link
US (2) US20130143760A1 (https=)
EP (1) EP2580592B1 (https=)
JP (1) JP6104796B2 (https=)
CN (1) CN103038642B (https=)
AU (1) AU2011263533B2 (https=)
BR (1) BR112012031444A2 (https=)
CA (1) CA2801863A1 (https=)
ES (1) ES2608956T3 (https=)
GB (1) GB201009798D0 (https=)
IN (1) IN2013CN00297A (https=)
WO (1) WO2011154698A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
US10928402B2 (en) 2012-12-28 2021-02-23 Nx Prenatal Inc. Treatment of spontaneous preterm birth
AU2015263998A1 (en) * 2014-05-22 2016-12-08 Northwestern University Gene expression profiles associated with sub-clinical kidney transplant rejection
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
BR112017007962A2 (pt) * 2014-10-24 2018-01-23 Koninklijke Philips Nv método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit
CA2976947C (en) * 2015-02-18 2023-02-28 Siemens Healthcare Diagnostics Inc. Locality-based detection of tray slot types and tube types in a vision system
TWI582240B (zh) * 2015-05-19 2017-05-11 鄭鴻鈞 以基因體預後評估試劑組預測乳癌患者局部區域復發風險及放射治療有效性的方法、用途及裝置
WO2017096405A1 (en) * 2015-12-04 2017-06-08 Nx Prenatal Inc. Use of circulating microparticles to stratify risk of spontaneous preterm birth
CN109444402B (zh) * 2018-12-18 2021-05-28 郑州安图生物工程股份有限公司 去甲肾上腺素发光免疫检测试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256713A (zh) * 1997-03-17 2000-06-14 约安·普斯卡斯 癌症的快速诊断方法
WO2007068985A2 (en) * 2005-12-16 2007-06-21 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
WO2009114862A1 (en) * 2008-03-14 2009-09-17 Dnar, Inc. Dna repair proteins associated with triple negative breast cancers and methods of use thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE12586T1 (de) 1980-05-02 1985-04-15 Edward P Davis Beinentlastungsgeraet.
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US5376531A (en) 1992-09-03 1994-12-27 Northwestern University Method of detecting cancer
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
EP1876241A3 (en) 1996-01-11 2008-07-30 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
AUPP525198A0 (en) 1998-08-13 1998-09-03 Medvet Science Pty. Ltd. Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof
US6492505B1 (en) 1999-02-01 2002-12-10 Incyte Genomics, Inc. Composition for detection of genes encoding membrane-associated proteins
WO2002101357A2 (en) 2001-06-10 2002-12-19 Irm Llc Molecular signatures of commonly fatal carcinomas
AU2003284880A1 (en) 2002-10-24 2004-05-13 Duke University Evaluation of breast cancer states and outcomes using gene expression profiles
US20040087571A1 (en) 2002-10-30 2004-05-06 Pfizer Inc Methods of using CCR1 antagonists as immunomodulatory agents
US20040259161A1 (en) 2003-03-12 2004-12-23 Fredrik Nilsson Screening assay
WO2004106495A2 (en) 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US20060019256A1 (en) 2003-06-09 2006-01-26 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
ATE491953T1 (de) * 2003-09-15 2011-01-15 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
JP4443568B2 (ja) 2003-10-15 2010-03-31 エフ．ホフマン−ラ ロシュ アーゲー 乳癌に対するマーカーとしてのタンパク質ａｓｃの使用
WO2005080570A1 (ja) 2004-02-24 2005-09-01 Mitsubishi Rayon Co., Ltd. 乳癌の術後予後予測に関与する遺伝子
US20090166224A1 (en) 2004-05-05 2009-07-02 Ziping Yang Multi-lectin affinity chromatography and uses thereof
WO2006105642A1 (en) 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
WO2007002069A2 (en) 2005-06-21 2007-01-04 Anthony Goncalves Serum biomarkers for breast cancer
US7972770B2 (en) 2005-08-16 2011-07-05 Memorial Sloan-Kettering Cancer Center Methods of detection of cancer using peptide profiles
EP1777523A1 (en) 2005-10-19 2007-04-25 INSERM (Institut National de la Santé et de la Recherche Médicale) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
US20080311601A1 (en) 2005-11-02 2008-12-18 Elting James J Methods for Prediction and Prognosis of Cancer, and Monitoring Cancer Therapy
SG142186A1 (en) 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
NZ562237A (en) 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
EP2105740A1 (en) * 2008-03-28 2009-09-30 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. Biomarkers for monitoring or predicting the treatment of cancer
EP2281063B1 (en) 2008-04-29 2014-10-15 Siemens Healthcare Diagnostics GmbH A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
JP2010151800A (ja) 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (en) 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
EP2391962B1 (en) 2009-01-28 2016-12-21 University of Notre Dame du Lac Accelerated progression relapse test
MX337650B (es) 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.
GB201009798D0 (en) 2010-06-11 2010-07-21 Immunovia Ab Method,array and use thereof
GB201410226D0 (en) 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256713A (zh) * 1997-03-17 2000-06-14 约安·普斯卡斯 癌症的快速诊断方法
WO2007068985A2 (en) * 2005-12-16 2007-06-21 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
WO2009114862A1 (en) * 2008-03-14 2009-09-17 Dnar, Inc. Dna repair proteins associated with triple negative breast cancers and methods of use thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer;Antonio ISIDORO, et al.;《Biochemical Journal》;20031219;第378卷(第1期);第17-20页 *
Breast Carcinomas Fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis;Antonio Isidoro, et al.;《CARCINOGENESIS》;20050720;第26卷(第12期);摘要，第2100页右栏第7行-第2101页左栏第23行 *
Differential exoprotease activities confer tumor-specific serum peptidome patterns.;Josep Villanueva, et al.;《The Journal of Clinical Investigation》;20060131;第116卷(第1期);第273页左栏第12-17行，附图5、6 *
Molecular response to aromatase inhibitor treatment in primary breast cancer;Alan Mackay, et al.;《Breast Cancer Research》;20070607;第9卷(第3期);第1-14页 *
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance;Djuana M.E.Harvell, et al.;《Breast Cancer Res Treat》;20080309;第112卷(第3期);第475-488页 *
Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays;Anders Carlsson, et al.;《European Journal of Cancer》;20080102;第44卷(第3期);摘要，第473页左栏第16-38行，第473页右栏第11行-第474页左栏第25行，第475页右栏第18行-477页左栏第10行，第477页左栏第33-50行，表2，附图2和3 *
Targeting Therapy for Breast Carcinoma by ATP Synthase Inhibit Aurovertin B;Tsui-Chin Huang, et al.;《Journal of Proteome Research》;20080430;第7卷(第4期);第1433-1444页 *
The tumor suppressor function of mitochondria: Translation into the clinics;Jose M.Cuezva, et al.;《Biochimica et Biophysica Acta》;20090123;第1792卷(第12期);第1145-1158页 *

Also Published As

Publication number Publication date
CN103038642A (zh) 2013-04-10
EP2580592A2 (en) 2013-04-17
WO2011154698A8 (en) 2013-01-17
BR112012031444A2 (pt) 2016-10-25
AU2011263533B2 (en) 2016-11-03
US10564163B2 (en) 2020-02-18
AU2011263533A8 (en) 2013-03-21
AU2011263533A1 (en) 2013-01-10
EP2580592B1 (en) 2016-10-05
US20180313852A1 (en) 2018-11-01
IN2013CN00297A (https=) 2015-07-03
WO2011154698A2 (en) 2011-12-15
JP2013529773A (ja) 2013-07-22
CA2801863A1 (en) 2011-12-15
ES2608956T3 (es) 2017-04-17
WO2011154698A3 (en) 2012-03-01
JP6104796B2 (ja) 2017-03-29
US20130143760A1 (en) 2013-06-06
GB201009798D0 (en) 2010-07-21

Similar Documents

Publication Publication Date Title
CN103038642B (zh) 方法、阵列及其用途
US20200088742A1 (en) Method, array and use for determining the presence of pancreatic cancer
US20220214344A1 (en) Method, array and use thereof
JP6465902B2 (ja) 腺癌の検出のための蛋白質シグネチャー／マーカー
JP2021165745A (ja) 方法、アレイ、およびその使用
JP2011505008A (ja) 診断方法及び診断に使用するためのアレイ
US10048265B2 (en) Methods and arrays for use in the same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170222

Termination date: 20180609